WALTHAM, Mass.--(BUSINESS WIRE)--Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, announces today that it has obtained an exclusive license to commercialize scientific patents created at the University of Rostock (Germany). The devices, which will in part be based on these patents, will allow Avedro to bring to market the first ever diagnostic device to accurately assess corneal biomechanical strength.
Help employers find you! Check out all the jobs and post your resume.
